A RECOMBINANT CELL LINE EXPRESSING GPCRx11 AS A FUNCTIONAL RECEPTOR VALIDATED BY ANGIOPEPTIN AND USEFUL FOR SCREENING OF AGONISTS AND ANTAGONISTS - Patent 1297003

(19)

(11)

EP 1 297 003 A2

(12)

(88)	Date of publication A3:
	02.05.2002

(43)	Date of publication:
	02.04.2003 Bulletin 2003/14

(21)	Application number: 01942923.2

(22)	Date of filing: 20.06.2001

(51)	International Patent Classification (IPC)⁷: C07K 14/00

(86)	International application number:
	PCT/BE0100/104

(87)	International publication number:
	WO 0109/8330 (27.12.2001 Gazette 2001/52)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

20.06.2000 US 212913 P
11.07.2000 US 217494 P
26.01.2001 EP 01870015
12.02.2001 EP 01870024

(71)	Applicant: Euroscreen S.A.
	1070 Brussels (BE)

(72)	Inventors:
	LANNOY, Vincent B-1200 Brussels (BE) BREZILLON, Stéphane B-1070 Brussels (BE) DETHEUX, Michel B-7000 Mons (BE) PARMENTIER, Marc B-1070 Brussels (BE) GOVARTS, Cédric B-1060 Brussels (BE)

(74)	Representative: De Clercq, Ann
	De Clercq, Brants & Partners,Edgard Gevaertdreef 10a 9830 Sint-Martens-Latem 9830 Sint-Martens-Latem (BE)

(54)	A RECOMBINANT CELL LINE EXPRESSING GPCRx11 AS A FUNCTIONAL RECEPTOR VALIDATED BY ANGIOPEPTIN AND USEFUL FOR SCREENING OF AGONISTS AND ANTAGONISTS